AVENUE THERAPEUTICS, INC.
AVENUE THERAPEUTICS, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 2 | 2 | 3 | 4 | 3 | 4 | 3 | 3 | 5 | 3 | 2 | 0 | |||||
Assets Current | |||||||||||||||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 2 | 2 | 3 | 4 | 4 | 4 | 3 | 3 | 5 | 3 | 2 | 1 | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Liabilities Current | |||||||||||||||||
Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | |||||
Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | |||||
Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 1 | 1 | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 3 | 2 | -5 | |||||
Additional Paid In Capital | 107 | 107 | 107 | 108 | 108 | 108 | 105 | 104 | 103 | 98 | 93 | 88 | |||||
Retained Earnings Accumulated Deficit | -107 | -106 | -105 | -105 | -104 | -104 | -103 | -101 | -98 | -95 | -91 | -92 | |||||
Minority Interest | - | - | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Liabilities And Stockholders Equity | 2 | 2 | 3 | 4 | 4 | 4 | 3 | 3 | 5 | 3 | 2 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 75 | 75 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | |||||
Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -43.40% | -47.17% | -47.99% | - | - | - | - | - | - | - | - | - |
| 2025 | 4.00% | 35.96% | 84.00% | 41.35% | 34.62% | 38.46% | 1.17% | -9.76% | -73.42% | 127.59% | -16.93% | 12.26% |
| 2024 | -7.40% | -8.36% | -28.22% | 2.63% | 1.41% | -11.11% | -2.13% | 9.57% | -27.66% | -16.00% | -30.41% | -0.42% |
| 2023 | - | - | - | -25.61% | -33.30% | -64.15% | -22.16% | -3.90% | -28.90% | -15.31% | -66.67% | -71.83% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
AVENUE THERAPEUTICS, INC. (ATXI) — SEC Financial Statements & Analysis
AVENUE THERAPEUTICS, INC. (ATXI) is a pharmaceutical preparations company, incorporated in DE. AVENUE THERAPEUTICS, INC. trades on OTC as: ATXI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), AVENUE THERAPEUTICS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 2.47x, a Price-to-Sales (P/S) ratio of 0.68x (TTM), a Price-to-Book (P/B) ratio of 1.62x (TTM), at a market cap of $922.59K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- 2.47x
- P/S TTM
- 0.68x
- P/B TTM
- 1.62x
- Market Cap
- $922.59K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AVENUE THERAPEUTICS, INC. in?
AVENUE THERAPEUTICS, INC. (ATXI) operates in the Pharmaceutical Preparations industry.
What is ATXI's market cap?
AVENUE THERAPEUTICS, INC. (ATXI) has a market capitalization of $922.59K as of 2026-06-30.
What exchange does ATXI trade on?
AVENUE THERAPEUTICS, INC. (ATXI) trades on the OTC.
Where is AVENUE THERAPEUTICS, INC. incorporated?
AVENUE THERAPEUTICS, INC. is incorporated in DE.